(c) 2024 PillSync.com

aminocaproic acid 500 mg

INDICATIONS AND USAGE Aminocaproic Acid Tablets USP are useful in enhancing hemostasis when fibrinolysis contributes to bleeding. In life-threatening situations, transfusion of appropriate blood products and other emergency measures may be required. Fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures) and portacaval shunt; hematological disorders such as amegakaryocytic thrombocytopenia (accompanying aplastic anemia); acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. Urinary fibrinolysis, usually a normal physiological phenomenon, may contribute to excessive urinary tract fibrinolytic bleeding associated with surgical hematuria (following prostatectomy and nephrectomy) or nonsurgical hematuria (accompanying polycystic or neoplastic diseases of the genitourinary system). (See WARNINGS .)

ANI Pharmaceuticals, Inc.


1 year ago OVAL WHITE AMG 3 19 aminocaproic acid 500 mg

OVAL WHITE AMG 3 19

HOW SUPPLIED

AMINOCAPROIC ACID Tablets USP, 500 mg Each oval, white to off-white tablet, engraved with AMG on one side and scored on the other with 3 to the left of the score and 19 on the right, contains 500 mg of

AMINOCAPROIC ACID. Bottle of 30 – NDC 62559-225-30 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in Tight Containers.


More pills like OVAL AMG 3 19












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site